On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJun 26, 2023 11:15 am

D-Wave Quantum Inc. (NYSE: QBTS) Supports Governments’ Investment in Near-Term Quantum Applications

D-Wave’s technology is geared toward optimization problems commonly faced by the public sector Governments worldwide are engaging with quantum computing to solve public sector problems and build domestic supply chains and workforces D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering value via practical quantum applications, is helping fuel the adoption of near-term quantum computing solutions against a backdrop of increased government assessment, investment and legislation. As more governments start to consider quantum applications and the use of quantum technologies to solve public sector challenges, D-Wave offers solutions oriented towards addressing optimization problems…

Continue Reading

MondayJun 26, 2023 10:30 am

Electronic Servitor Publication Network Inc. (XESP) Announces a New Channel Partner, IBN, to Help Provide Additional Growth-Focused Services

IBN has been named a new Channel Partner within XESP’s Channel Partner Program The value-add approach gives customers additional growth-focused services from a trusted point of contact XESP and IBN previously announced signing mutual definitive service agreements between the parties, with Channel Partner as a natural progression of the relationship Electronic Servitor Publication Network (OTCQB: XESP), a market disruptor for B2B companies using cutting-edge data analysis and smart technology, has announced a new Channel Partner with the addition of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://nnw.fm/qm0Ug). The XESP Channel Partner Program allows…

Continue Reading

MondayJun 26, 2023 9:45 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Prepares to Meet the Fuel Cell Industry’s Rising Demand for Graphite

Adoption of fuel cell technology hinges on the availability of high-purity graphite for specific fuel cell components The Ruby Graphite project is the only known combined graphite flake and vein graphite source in the U.S., recent samples assay at 95.8% to 98.4% total carbon RFLXF acquired the Ruby Graphite project in 2022, holds mining rights for 755 hectares with 96 federal lode mining claims Other graphite applications include the use of specialized fire retardants, in high-speed machinery; as a refractory material in certain manufacturing processes; as a crucial component in lithium-ion batteries; and as a moderator in specific types of…

Continue Reading

MondayJun 26, 2023 9:00 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Makes Strategic Moves as Blockchain Continues To Influence the Remittance Industry

FEXD’s aggressive expansion plan not only lines up with its core mission but is also a step toward carving out a significant market share in the global fintech market, which is projected to hit $500 billion in valuation by 2028 The company is exploring blockchain technology, banking on how easier access to mobile phones has helped make money transfers more accessible FEXD is also optimistic that the technology it will not only cut down on the cost of transactions but also significantly grow its annual revenues Its management is confident in this approach, citing that the investments so far will…

Continue Reading

FridayJun 23, 2023 11:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Enters New Stage With Dedicated AI Development Division

Texas-headquartered Freight Technologies (aka Fr8Tech) is a technology innovation company dedicated to sustaining over-the-road (“OTR”) commercial shipments within the USMCA (formerly NAFTA) North American trading area The company’s core Fr8App product is a cloud-based freight matching platform that uses artificial intelligence and machine learning to help shippers and carriers match up their loads, capacity, and destinations Fr8Tech is growing its artificial intelligence development, appointing Dr. Umberto León-Domínguez to oversee the creation of a dedicated AI department Fr8App was recently cited by Google Maps Platform’s blog as an innovative use of advanced markers from the platform to interactively help end users…

Continue Reading

FridayJun 23, 2023 10:30 am

If the PGA Tour and LIV Golf had used GolfLync Inc., Maybe They Would Have Gotten Along Better

Golf is about doing something you like, with people you like – what a concept. It’s hard to blame players and golf lovers from feeling blindsided by the announcement of a full-blown merger between two of golf’s major tours. The unexpected agreement between PGA Tour commissioner Jay Monahan and Saudi businessman Yasir bin Othman Al-Rumayyan, governor of the Saudi Public Investment Fund (“PIF”), that the PGA and LIV Golf would suddenly merge, was out-of-the-blue. After months of increasingly rancorous suits and court battles, “merger” wasn’t a term seen on a lot of radar screens.   The PGA Tour, hosting tournaments in…

Continue Reading

FridayJun 23, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) CMO Discusses Recent Company Announcements in Bell2Bell Podcast Episode

Genprex Chief Medical Officer, Dr. Mark Berger, was featured in a recent Bell2Bell Podcast episode, where he discussed the company’s recent announcements In May, the company received Safety Review Committee (“SRC”) approval to advance to the Phase 2 expansion portion of its Acclaim-1 clinical trial of its lead candidate, REQORSA(R) Immunogene Therapy The Phase 1 dose escalation portion of the study showed that REQORSA(R) was generally well tolerated, and there were no dose-limiting toxicities; Genprex also reported encouraging evidence of efficacy in this portion In April, Genprex announced that its research collaborators presented in vivo mouse data showing that Genprex’s…

Continue Reading

FridayJun 23, 2023 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Expands Collaboration with NVIDIA, Releases New Financial Update Revealing Progress on Volume Production

Cepton integrated Vista-X120 Plus lidar into NVIDIA Omniverse platform to enable real-time simulation and 3D visualization to streamline lidar deployment processes and reduce cost for automakers Vista-X120 Plus features a software-definable ROI, allows users to dynamically adjust and optimize lidar performance and power consumption based on specific scenarios or areas that require additional attention Cepton released a financial update revealing it was on track to receive final production validation for salable vehicles and continue shipment of pre-production lidar units for multiple vehicle models Additional update highlights included completed implementation of embedded lidar software, and execution of RFQ and RFI responses…

Continue Reading

ThursdayJun 22, 2023 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Findings in Diabetes Animal Study and Two Other R&D Programs

Diabetes – Blood glucose levels reduced by 19.9% with patented DehydraTECH(TM) processed CBD Epilepsy – Lower dosages of DehydraTECH-CBD were needed to achieve the same results of Epidiolex(R) in the company’s animal epilepsy study Dementia – Lexaria determined that a longer testing duration is needed for DehydraTECH-CBD in cognition studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, including the company’s patented DehydraTECH(TM) technology, recently reported additional findings from its diabetes animal study DIAB-A22-1, as well as updates on two other applied R&D programs for dementia (DEM-A22-1) and epilepsy (EPIL-A21-1). In March, Lexaria announced that it had…

Continue Reading

ThursdayJun 22, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Gains Exclusive Development and Commercialization License from Max Planck for biobetter Anti-IL-17 Antibody

BiondVax just signed an exclusive worldwide license agreement with the Max Planck Society to develop and commercialize innovative NanoAb therapeutics for the treatment of psoriasis and psoriatic arthritis Part of an ongoing broad-based collaboration targeting therapies addressing diseases such as Covid-19, asthma, and macular degeneration Per BiondVax’s CEO, Amir Reichman, this exclusive license presents an exciting opportunity to develop a unique treatment for psoriasis BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products mainly for treating infectious and autoimmune diseases, just announced that it has signed an exclusive worldwide license agreement to develop…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217